Discontinued — last reported Q2 '23
Johnson & Johnson Consumer — Goodwill (Note 3) decreased by 1.6% to $9.08B in Q2 2023 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $9.15B to $9.08B.
An increase suggests recent acquisitions, while a decrease may indicate impairment charges or divestitures.
This represents the carrying value of goodwill specifically allocated to the Consumer Health operating segment as disclo...
Peers in the consumer packaged goods and pharmaceutical sectors report segment-level goodwill to show acquisition history.
jnj_segment_consumer_health_goodwill_note_3| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $10.09B | $9.98B | $9.81B | $9.62B | $9.15B | $8.77B | $9.18B | $9.23B | $9.08B |
| QoQ Change | — | -1.0% | -1.7% | -2.0% | -4.9% | -4.1% | +4.7% | +0.5% | -1.6% |
| YoY Change | — | — | — | — | -9.3% | -12.1% | -6.4% | -4.0% | -0.7% |